Ausdal Financial Partners, Inc. Tiziana Life Sciences LTD Transaction History
Ausdal Financial Partners, Inc.
- $880 Million
- Q2 2024
A detailed history of Ausdal Financial Partners, Inc. transactions in Tiziana Life Sciences LTD stock. As of the latest transaction made, Ausdal Financial Partners, Inc. holds 55,700 shares of TLSA stock, worth $53,472. This represents 0.01% of its overall portfolio holdings.
Number of Shares
55,700
Previous 55,700
-0.0%
Holding current value
$53,472
Previous $25,000
104.0%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TLSA
# of Institutions
27Shares Held
929KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA220KShares$210,7400.0% of portfolio
-
Hsbc Holdings PLC London, X0125KShares$120,3500.0% of portfolio
-
Morgan Stanley New York, NY111KShares$106,0950.0% of portfolio
-
Zhang Financial LLC55.9KShares$53,6510.0% of portfolio
-
Ubs Group Ag51.6KShares$49,5520.0% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $98.2M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...